30 October 2019 2 Min Read
Glaxo expects better profit after good sales of shingles vaccine
CEO Emma Walmsley has embarked on a plan to rejuvenate Glaxo, which has included the spin off or sale of some units since she took over in 2017
Subscribe to our website to read this article and support quality journalism.
If you’ve already subscribed, simply sign in.
Subscribe Sign In